GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging

The study explores the potential therapeutic effects of the copper-binding tripeptide GHK-Cu in combating age-related neurodegenerative diseases, such as Alzheimer's and Parkinson's.

Key findings from the study include:

• Antioxidant Properties: GHK-Cu exhibits significant antioxidant activity, which may help mitigate oxidative stress—a major contributor to neurodegeneration.

• Anti-Inflammatory Effects: The peptide demonstrates anti-inflammatory actions, potentially reducing neuroinflammation associated with cognitive decline.

• Gene Expression Modulation: GHK-Cu influences the expression of numerous human genes, promoting a shift towards a healthier state. This gene-modulating capability may underlie its diverse health-promoting effects.

• Potential Therapeutic Role: Given its antioxidant, anti-inflammatory, and gene-modulating properties, GHK-Cu is proposed as a potential therapeutic agent against age-associated neurodegeneration and cognitive decline.

The study suggests that GHK-Cu's multifaceted biological activities could make it a promising candidate for interventions aimed at preventing or mitigating degenerative conditions associated with aging, particularly those affecting cognitive health.